Home
>
US Stocks
>
Cortexyme Inc
Cortexyme Inc
CRTX

Cortexyme Inc (CRTX)

$59.242.02%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$60.85
Today Low/High
$59.2 / $63.93
52 Week Low/High
$26.66 / $121.98
Market Cap
$2.68B

Company Details

Cortexyme, Inc. is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Based upon the evidence generated to date, Cortexyme is currently advancing its lead therapeutic candidate, atuzaginstat (COR388), in the GAIN Trial, an ongoing Phase 2/3 clinical trial in patients with mild to moderate Alzheimer's disease. Cortexyme is targeting a specific, infectious pathogen found in the brain and other organs and tied to degeneration and inflammation in humans and animal models.
Organisation
Cortexyme Inc
Employees
38
Industry
Biotechnology

Discover more

Frequently Asked Questions

What is Cortexyme Inc (CRTX) share price today?

Can Indians buy Cortexyme Inc (CRTX) shares?

How can I buy Cortexyme Inc (CRTX) shares from India?

Can Fractional shares of Cortexyme Inc (CRTX) be purchased?

What are the documents required to start investing in Cortexyme Inc (CRTX) stocks?

We are a SEBI registered investement advisor